Abstract: Gold implant having a cross-section in the range of 20-100, preferably in the range of 20-40 ?m for use in therapy to prevent or reduce capsular contracture. Further, the invention relates to a method of producing a gold-coated implant.

Abstract: An implantable device comprising a core portion and a capsule encapsulating the core portion, said capsule having an outer surface, wherein at least a portion of the outer surface comprises gold.

Abstract: A gold particle having at least one cross-section in the range of 20-1000 ?m and having a purity greater than 99.00% w/w, preferably 99.99% w/w for use in treatment of a wound to minimize scar formation and to prevent abnormal scar formation. A composition comprising at least one gold particle having at least one cross-section in the range of 20-1000 ?m and having a purity greater than 99.00% w/w, preferably 99.99% w/w for use in treatment of a wound to prevent abnormal scar formation, wherein the composition further comprises hyaluronic acid or any other physiologically acceptable carrier.

Abstract: Gold implant having a cross-section in the range of 20-100, preferably in the range of 20-40 ?m for use in therapy to prevent or reduce capsular contracture. Further, the invention relates to a method of producing a gold-coated implant.

Abstract: Sterile micron-sized gold particles contained in capped vials, a kit of part including the vial and a liquid capable of suspending the particles, as well as their preparation, medical devices or medicaments prepared by their preparation as well as uses thereof in treating inflammation. Also, gold coated implants preferably for use in combination with the medical devices.

Abstract: Sterile micron-sized gold particles contained in capped vials, a kit of part including the vial and a liquid capable of suspending the particles, as well as their preparation, medical devices or medicaments prepared by their preparation as well as uses thereof in treating inflammation. Also, gold coated implants preferably for use in combination with the medical devices.

Abstract: An implantable device comprising a core portion and a capsule encapsulating the core portion, said capsule having an outer surface, wherein at least a portion of the outer surface comprises gold.

Abstract: A gold particle having at least one cross-section in the range of 20-1000 ?nm and having a purity greater than 99.00% w/w, preferably 99.99% w/w for use in treatment of a wound to minimize scar formation and to prevent abnormal scar formation. A composition comprising at least one gold particle having at least one cross-section in the range of 20-1000 ?m and having a purity greater than 99.00% w/w, preferably 99.99% w/w for use in treatment of a wound to prevent abnormal scar formation, wherein the composition further comprises hyaluronic acid or any other physiologically acceptable carrier.

Abstract: Sterile micron-sized gold particles contained in capped vials, a kit of part including the vial and a liquid capable of suspending the particles, as well as their preparation, medical devices or medicaments prepared by their preparation as well as uses thereof in treating inflammation. Also, gold coated implants preferably for use in combination with the medical devices.

Abstract: A method of treatment of a diseased patient in which a dose of at least one heavy metal is delivered to the patient, with a surface area which is accessible for direct contact with the patient's tissue and effects release of heavy metal ions for uptake by immuno reactive cells. The criteria to be complied with in order for the heavy metal to be effective is that the surface area is greater than the surface area of a solid sphere of the same at least one heavy metal, and that the solid sphere and dose have the same weight. In a preferred embodiment, the dose of heavy metals is delivered to the patient as very small hollow particles.

Abstract: A method of treatment of a diseased patient in which a dose of at least one heavy metal is delivered to the patient, with a surface area which is accessible for direct contact with the patient's tissue and effects release of heavy metal ions for uptake by immuno reactive cells. The criteria to be complied with in order for the heavy metal to be effective is that the surface area is greater than the surface area of a solid sphere of the same at least one heavy metal, and that the solid sphere and dose have the same weight. In a preferred embodiment, the dose of heavy metals is delivered to the patient as very small hollow particles.

Abstract: The present invention relates to a method and a heavy metal, such as noble metal. E.g. gold, for implantation in vivo or in vitro in local areas in humans or animals, the gold is provided with a large surface to ensure ample release of gold ions. The heavy metal e.g. gold may be admixed to solids, (tablets, powders) liquids (solutions, lung sprays, eye drops, nose spray) or cremes, depending on how it is going to be used, on the different external or internal epithelial surfaces. Form implantation in tissues including the brain, the gold is provided as pieces of gold having a mass and surface adapted to the purpose, where the surface of the piece of gold is larger than a cylindrical piece of gold having the same mass. In a preferred embodiment, the pieces of gold are wound as springs.

Abstract: An organometallic probe comprising a colloidal core, for example a ,old colloid, to which a membrane translocating signal (MTS), for example an HIV-tat fragment, is directly attached. The organometallic probe is suited for silver enhancement techniques.